- Home
- OPTN vs WHG Comparison
OPTN vs WHG Comparison
Compare OPTN & WHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTN
- WHG
- Stock Information
- Founded
- OPTN 2010
- WHG 1983
- Country
- OPTN United States
- WHG United States
- Employees
- OPTN N/A
- WHG N/A
- Industry
- OPTN Biotechnology: Pharmaceutical Preparations
- WHG Investment Managers
- Sector
- OPTN Health Care
- WHG Finance
- Exchange
- OPTN Nasdaq
- WHG Nasdaq
- Market Cap
- OPTN 117.6M
- WHG 132.4M
- IPO Year
- OPTN 2017
- WHG 2002
- Fundamental
- Price
- OPTN $0.71
- WHG $14.40
- Analyst Decision
- OPTN Strong Buy
- WHG
- Analyst Count
- OPTN 2
- WHG 0
- Target Price
- OPTN $4.00
- WHG N/A
- AVG Volume (30 Days)
- OPTN 516.5K
- WHG 11.8K
- Earning Date
- OPTN 11-07-2024
- WHG 10-29-2024
- Dividend Yield
- OPTN N/A
- WHG 4.16%
- EPS Growth
- OPTN N/A
- WHG N/A
- EPS
- OPTN N/A
- WHG 0.72
- Revenue
- OPTN $75,058,000.00
- WHG $90,529,000.00
- Revenue This Year
- OPTN $24.44
- WHG N/A
- Revenue Next Year
- OPTN $49.00
- WHG N/A
- P/E Ratio
- OPTN N/A
- WHG $20.12
- Revenue Growth
- OPTN 3.91
- WHG 12.41
- 52 Week Low
- OPTN $0.65
- WHG $8.91
- 52 Week High
- OPTN $2.10
- WHG $15.19
- Technical
- Relative Strength Index (RSI)
- OPTN 33.40
- WHG 63.69
- Support Level
- OPTN $0.65
- WHG $13.98
- Resistance Level
- OPTN $0.70
- WHG $14.68
- Average True Range (ATR)
- OPTN 0.05
- WHG 0.53
- MACD
- OPTN -0.00
- WHG 0.07
- Stochastic Oscillator
- OPTN 24.67
- WHG 70.19
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.
About WHG Westwood Holdings Group Inc
Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals, and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high-net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.